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Aortic Reconstruction
J.R. Boyle
Cambridge Vascular Unit, Cambridge University Hospitals NHS Trust, Cambridge, UKThis is an important manuscript reporting the results of
native aortic and aortic graft infections managed with cry-
opreserved aortic allografts in a large series of patients. The
main ﬁnding is the relatively high graft-related complication
rates of nearly 20% at a median follow-up of just over 1 year.1
Ten patients developed early graft complications, the
most concerning being the four cases of allograft body
disruption and two anastomotic disruptions, which brings
into question the ability of the aortic graft to withstand the
cryopreservation process while maintaining its inherent
integrity to pulsatile aortic pressures. The four cases of mid-
allograft rupture occurred in patients with more virulent
Gram-negative infection or after the treatment of aorto-
enteric ﬁstula, potentially higher risk groups. Notwith-
standing this however, as the authors recognise in their
discussion the high early graft-related complications as the
main impediment to the use of cryopreserved allografts.
They also recognise the concerns of late degenerative
changes in both fresh and cryopreserved allografts.
This series highlights the difﬁculties of obtaining robust
long-term follow-up data in this patient cohort. These cases
are rare and therefore the literature is littered with case re-
ports and small series. This unit has a large aortic practice;
their own prosthetic aortic graft infection rate was 1.4%, with
over 40% of the cases described above having undergone
their primary aortic procedures at other units. These patients
have both high short- and medium-term mortality rates, the
authors reporting 39% mortality at a median of just 12
months’ follow-up. A recent study of 25 patients, also from
France, using cryopreserved allografts reported an in-hospital
mortality rate of 48%.2 Longer-term mortality rates of 54% at
2.5 years in the USA have been reported in a contemporary
series, which also highlighted the high in-hospital mortality
rates associated with aorto-enteric ﬁstulae.3
Both French series identiﬁed age and chronic renal
impairment as poor prognostic factors, in keeping with
many other vascular conditions.1,2 The usefulness of these
poor prognostic indicators is debatable when the outcomes
of conservative management of aortic graft infection are
extremely poor. The authors have only included data on
patients who underwent aortic reconstruction with allo-
grafts, and have not reported outcomes for patients whoDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.04.023
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http://dx.doi.org/10.1016/j.ejvs.2014.05.024did not undergo any intervention for aortic infection due to
frailty or prohibitive surgical risk.
Despite their rarity, cases of primary aortic and aortic graft
infection present a major challenge to the vascular surgeon.
My preference is for superﬁcial femoral vein reconstruction if
the conduit is available and the patient’s condition allows.
Harvesting superﬁcial femoral vein is time consuming, but
can be achieved even in the emergency situation. This tech-
nique is particularly attractive when replacing an aortic tube
graft or treating a primarily infected infra-renal aorta, and is
much less appealing when faced with replacing a bifurcated
graft, particularly if it extends the groins. Eshan et al.4 re-
ported a 5-year survival of 70% using superﬁcial femoral vein
reconstruction, as good as for primary aortic aneurysm
repair.5 A recent survey of Dutch Vascular Surgeons identiﬁed
in situ venous reconstruction as the surgeon’s ﬁrst choice.6
Certainly vascular surgeons have a number of options when
faced with native aortic or aortic graft infection, the data
presented here have reinforced my views that in situ superﬁ-
cial vein replacement is superior to cryopreserved allografts
and antibiotic bonded prosthetic grafts. Extra-anatomic
bypass still has an important role, particularly in patients
with aorto-enteric ﬁstulae and highly virulent infections where
the risk of reinfection of in situ reconstruction remains high.
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